Genetic Variants May Explain High Levels of Antibodies Against Epstein-Barr Virus & 5 Myths About MS
Sep 07, 2020, 12:00 AM
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how genetic variance may contribute to the increased levels of antibodies against proteins of the Epstein-Barr virus. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to Enabled column entitled 5 Myths About MS That Are Actually Not True.
=====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
https://multiplesclerosisnewstoday.com/forums/